Jean Eloy, MD
Otolaryngology · Newark, NJNPI 1295997500
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $6,400 of the $8,114 with a category attached, or 78.9%. Medtronic accounts for 80.3% of it on its own, with 8 other manufacturers making up the rest. Among otolaryngology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 22 payments — averaging $368.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Intersect ENT, Inc.$617
- Stryker$549
- 3-d Matrix, Inc.$175
- Acclarent, Inc$160
- Amgen$34
- plus $59 from 3 others
What the payments were for
- Speaking & faculty fees$6,40079%
- Food & beverage$1,68021%
- Education$340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 3 | $6,519 |
| Intersect ENT, Inc. | 5 | $617 |
| Stryker | 7 | $549 |
| 3-d Matrix, Inc. | 1 | $175 |
| Acclarent, Inc | 2 | $160 |
| Amgen | 1 | $34 |
| Olympus America Inc. | 1 | $24 |
| Haemonetics Corporation | 1 | $20 |
| Eyepoint US, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STRAIGHTSHOT$3,840
- QUADCUT$2,560
- PROPEL$401
- Navigation CUBE$176
- SCOPIS ENT$151
- N/A$131
- NUVENT$119
How this compares
$8,114 in reported general payments places this provider in the 95th percentile of 232 otolaryngology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 12 | $45,876 |
| Fluticasone Propionate | 291 | $4,003 |
| Azelastine Hcl | 98 | $2,920 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 64 | $731 |
| Ipratropium Bromide | 16 | $225 |
| Montelukast Sodium | 13 | $183 |
| Prednisone | 79 | $168 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Newark
- Wayne HsuehNewark$7K
- Ghayoour MirNewark$5K
- Evelyne KalyoussefNewark$4K
- Roman PovolotskiyNewark$3K
- Nishant ReddyEast Windsor$133K
- Giant LinFlorham Park$25K
- Samir ShahVoorhees$16K
- Brian BensonHackensack$14K
- Andrew BlitzerHackensack$9K
- Ahmad MahmoudClifton$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.